life.jpg
LifeVantage Corporation Receives Approval to List on the NASDAQ Capital Market
September 10, 2012 16:03 ET | Lifevantage Corporation
SALT LAKE CITY, Sept. 10, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation (OTCBB:LFVN), a company dedicated to helping people achieve healthy living through a combination of a compelling business...
life.jpg
LifeVantage Announces Record Fourth Quarter and Full Fiscal Year 2012 Results
September 10, 2012 16:01 ET | Lifevantage Corporation
Company Receives Approval to List on The Nasdaq Capital Market Fourth Quarter Net Revenue Increases 197% Over Prior Year Period to $44.6 Million Fourth Quarter Operating Income Improves to a...
life.jpg
LifeVantage to Announce Fiscal Fourth Quarter and Full Year 2012 Results on September 10, 2012
August 31, 2012 16:00 ET | Lifevantage Corporation
SALT LAKE CITY, Aug. 31, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation (OTCBB:LFVN), the leader in Nrf2 science and the maker of Protandim®, the Nrf2 Synergizer® patented dietary...
life.jpg
LifeVantage Makes a Charitable Donation to Deworm the World
August 09, 2012 16:01 ET | Lifevantage Corporation
SALT LAKE CITY, Aug. 9, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation (OTCBB:LFVN), the leader in Nrf2 science and the maker of Protandim®, the Nrf2 Synergizer® patented dietary...
life.jpg
LifeVantage Corporation Completes Previously Announced CFO Transition
August 06, 2012 09:00 ET | Lifevantage Corporation
SALT LAKE CITY, Aug. 6, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation (OTCBB:LFVN), the leader in Nrf2 science and the maker of Protandim®, the Nrf2 Synergizer® patented dietary...
life.jpg
LifeVantage Corporation Makes a Charitable Donation to Hunger Relief International
July 20, 2012 19:24 ET | Lifevantage Corporation
SALT LAKE CITY, July 20, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation (OTCBB:LFVN), the leader in Nrf2 science and the maker of Protandim®, the Nrf2 Synergizer® patented dietary...
life.jpg
LifeVantage Announces Protandim(R) Subject of New Peer-Reviewed Article
June 27, 2012 15:01 ET | Lifevantage Corporation
Oxidative Medicine and Cellular Longevity Article Reports Protandim® Protects Human Coronary Artery Endothelial Cells Against Oxidative Challenge SALT LAKE CITY, June 27, 2012 (GLOBE...
life.jpg
LifeVantage to Present at the Accredited Members Summer 2012 Investment Conference
June 07, 2012 09:27 ET | Lifevantage Corporation
SALT LAKE CITY, June 7, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation (OTCBB:LFVN), the leader in Nrf2 science and the maker of Protandim®, the Nrf2 Synergizer™ patented dietary...
life.jpg
LifeVantage Corporation Expands Management Team to Further Strategic Corporate Objectives
June 01, 2012 11:00 ET | Lifevantage Corporation
SALT LAKE CITY, June 1, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation (OTCBB:LFVN), the leader in Nrf2 science and the maker of Protandim®, the Nrf2 Synergizer® patented dietary...
life.jpg
LifeVantage Announces Record Third Quarter Fiscal Year 2012
May 15, 2012 16:01 ET | Lifevantage Corporation
Net Revenue Increases 263% Over Prior Year Period to $36.2 Million Operating Income Improves to a Record $6.4 Million Company Raises Full Year Fiscal 2012 Revenue and Operating Margin...